Edwards Lifesciences (EW) Net Income (2009 - 2026)

Edwards Lifesciences has reported Net Income for 18 years, with the latest figure at $241.4 million in Q2 2026.

• On a quarterly basis, Net Income fell 27.18% year-over-year to $241.4 million in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 75.77% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 74.35% from the prior year.
• Net Income was $241.4 million for Q2 2026 at Edwards Lifesciences, down from $380.7 million in the prior quarter.
• The five-year high for Net Income was $3.1 billion in Q3 2024, with the low at $91.2 million in Q4 2025.
• Average Net Income over 5 years is $479.3 million, with a median of $360.7 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Net Income jumped 699.95% in 2024, then tumbled 90.54% in 2025.
• Over 5 years, Net Income stood at $200.5 million in 2022, then surged by 84.39% to $369.7 million in 2023, then rose by 3.95% to $384.3 million in 2024, then sank by 76.27% to $91.2 million in 2025, then soared by 164.69% to $241.4 million in 2026.
• The last three Net Income figures came in at $241.4 million (Q2 2026), $380.7 million (Q1 2026), and $91.2 million (Q4 2025), per Business Quant data.